Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-24 Purchase |
2025-01-02 08:58 am |
Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO |
2,299 | $2.87 | $6,598 | 262,000 (Direct) |
View |
| 2024-08-27 Purchase |
2024-09-12 3:23 pm |
Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO |
5,101 | $3.37 | $17,190 | 259,701 (Direct) |
View |
| 2024-06-21 Purchase |
2024-07-02 11:47 am |
Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO |
1,600 | $2.8 | $4,480 | 254,600 (Direct) |
View |
| 2023-12-27 Purchase |
2024-01-03 11:48 am |
Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO |
2,700 | $4.76 | $12,852 | 253,000 (Direct) |
View |
| 2023-12-14 Purchase |
2023-12-18 5:30 pm |
Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO |
900 | $4.92 | $4,428 | 250,300 (Direct) |
View |
| 2023-12-06 Purchase |
2023-12-11 2:04 pm |
Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO |
1,500 | $5.07 | $7,605 | 249,400 (Direct) |
View |
| 2023-09-11 Purchase |
2023-09-18 10:04 am |
Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO |
1,500 | $5.43 | $8,145 | 247,900 (Direct) |
View |
| 2023-08-28 Purchase |
2023-09-05 07:43 am |
Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO |
3,400 | $4.69 | $15,946 | 246,400 (Direct) |
View |
| 2023-08-18 Purchase |
2023-08-28 10:13 am |
Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO |
8,000 | $4.32 | $34,560 | 243,000 (Direct) |
View |
| 2022-12-12 Sale |
2023-01-05 2:26 pm |
Biostage Inc. | BSTG | He Junli Director |
135 | $6.83 | $922 | 235,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-11 Option Award |
2024-01-12 8:09 pm |
N/A 2034-01-11 |
Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO |
220,640 | $0 | 220,640 (Direct) |
View |
| 2023-04-10 Option Award(A) |
2023-07-10 3:47 pm |
N/A 2033-04-10 |
Biostage Inc. | BSTG | He Junli CEO |
267,616 | $0 | 267,616 (Direct) |
View |
| 2023-04-10 Option Award |
2023-04-12 11:24 am |
N/A 2033-04-10 |
Biostage Inc. | BSTG | He Junli CEO |
1,220,640 | $0 | 1,220,640 (Direct) |
View |
| 2022-06-29 Option Award |
2022-07-01 5:48 pm |
N/A 2032-06-29 |
Biostage Inc. | BSTG | He Junli Director |
11,257 | $0 | 11,257 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 7:02 pm |
2022-05-18 2032-05-18 |
Biostage Inc. | BSTG | He Junli Director |
6,813 | $0 | 6,813 (Direct) |
View |
| 2021-09-05 Option Award |
2021-11-10 8:38 pm |
N/A 2031-09-05 |
Biostage Inc. | BSTG | He Junli Director |
19,622 | $0 | 30,517 (Direct) |
View |
Ownership |
2021-11-10 8:36 pm |
N/A N/A |
Biostage Inc. | BSTG | He Junli Director |
0 | $0 | 235,135 (Direct) |
View |